Table 1 Clinical characteristics of patients with NSCLC included in this study
From: Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort
| Â | N (%) |
|---|---|
Total | 117 (100) |
Age | Â |
< 70 | 100 (85.5) |
≥ 70 | 17 (14.5) |
Gender | Â |
Male | 72 (61.5) |
Female | 45 (38.5) |
Smoking | Â |
Never smoke | 57 (48.7) |
Current or former | 60 (51.3) |
Metastasis | Â |
Yes | 78 (66.7) |
No | 39 (33.3) |
Histology | Â |
Squamous | 15 (12.8) |
Adenocarcinoma | 96 (82.1) |
Other | 6 (5.1) |
Stage at diagnosis | Â |
I | 6 (5.1) |
II | 2 (1.7) |
III | 17 (14.5) |
IV | 92 (78.6) |
First-line therapy | Â |
Targeted therapy | 44 (37.6) |
Chemotherapy | 55 (47.0) |
Other | 18 (15.4) |